PIK3CA amplification has also been found to be associated with poor prognosis in HNSCC patients without lymph node metastasis, and therefore could be a potential prognostic marker [43]. The gene discussed is PIK3CA; the disease is metastatic malignant neoplasm in the lymph nodes.